Showing 7161-7170 of 8649 results for "".
- Ciliatech Releases New Design of Glaucoma Surgical Device CIDhttps://modernod.com/news/ciliatech-releases-new-design-of-glaucoma-surgical-device-cid/2481993/Ciliatech announced the release of a new design of its CID (cilioscleral interpositioning device) following the filing of additional patents strengthening its IP (intellectual property). CID is the unique glaucoma surgical device used in the cilioscleral technique to lower IOP whil
- Corza Medical Opens Ophthalmology Center of Technology and Innovationhttps://modernod.com/news/corza-medical-opens-ophthalmology-center-of-technology-and-innovation/2481992/Corza Medical announced the opening of its new Ophthalmology Center of Technology and Innovation in St. Louis. The state-of-the-art facility is aimed at advancing the development of next-generation devices for ophthalmic surgeries and other eye treatments. With an approximate footp
- Skye Bioscience Begins Phase 2 Study of SBI-100 Ophthalmic Emulsion to Treat Glaucomahttps://modernod.com/news/skye-bioscience-begins-phase-2-study-of-sbi-100-ophthalmic-emulsion-to-treat-glaucoma/2481984/Skye Bioscience, which is developing drugs targeting the endocannabinoid system and focusing on glaucoma and metabolic conditions, announced it has treated the first patient in its phase 2 clinical trial evaluating SBI-100 ophthalmic emulsion’s ability to lower IOP as well as safe
- Ocuphire Pharma Names Joseph Schachle as COOhttps://modernod.com/news/ocuphire-pharma-names-joseph-schachle-as-coo/2481981/Ocuphire Pharma announced the appointment of Joseph (Joe) K. Schachle, MBA, into the newly created role of Chief Operating Officer, effective immediately. Ocuphire is a clinical-stage company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refra
- Emily Chew, MD, Named NIH Distinguished Investigatorhttps://modernod.com/news/emily-chew-md-named-nih-distinguished-investigator/2481980/Emily, Chew, MD, has been promoted to the title of NIH Distinguished Investigator for her work as a care provider and clinical trialist. Dr. Chew directs National Eye Institute's Division of Epidemiology and Clinical Applications (DECA). An ophthalmologist, she specializes in c
- Pixium Vision Receives Takeover Offerhttps://modernod.com/news/pixium-vision-receives-takeover-offer/2481976/Pixium Vision, whose safeguard proceedings were converted into receivership by the Paris Commercial Court on November 13, 2023, announced that the court-appointed administrators have received a takeover offer for the assets and activities of Pixium. The name of the a
- Berkeley Scientists Discover Retinal Cells that Help Stabilize Our World Viewhttps://modernod.com/news/berkeley-scientists-discover-retinal-cells-that-help-stabilize-our-world-view/2481975/Herbert Wertheim School of Optometry & Vision Science researchers have discovered rare neurons in the eye that are crucial for our visual system to maintain a sharp, steady image of the world. These findings may impact our understanding of the human retina and provide insights
- Injectsense and Injectpower Secure $9.4M to Support Injectsense's First-in-Human Studies for Sensors that Continuously Measure IOPhttps://modernod.com/news/injectsense-and-injectpower-secure-94m-to-support-injectsenses-first-in-human-studies-for-sensors-that-continuously-measure-iop/2481973/Injectsense and sister company Injectpower, a developer of ultra-miniature solid-state microbatteries for medical applications, announced combined funding of $9.4 million to bring highly integrated autonomous implantable devices—smaller than a grai
- Research Unveils Potential Breakthrough in Diabetic Retinopathy Treatmenthttps://modernod.com/news/research-unveils-potential-breakthrough-in-diabetic-retinopathy-treatment/2481962/Researchers from Washington University in St. Louis have discovered a potential new treatment approach to diabetic retinopathy. Diabetic retinopathy’s enigma unfolds with the role of microglia, immune cells resident in the retina. When confronted with high blood glucose levels, th
- Study: Racial Disparities in Glaucoma Care Persist, Regardless of Socioeconomic Statushttps://modernod.com/news/study-racial-disparities-in-glaucoma-care-persist-regardless-of-socioeconomic-status/2481961/Many studies have shown that glaucoma is more common and more severe in Black and Hispanics than in Whites, but less is known about the impact of racial differences and socioeconomic status on vision loss and individual utilization of health care resources among glaucoma patients, according